Inovio Pharmaceuticals INO
NASDAQ INO
$0.84 +0.04 (+5.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Inovio Pharmaceuticals (INO) Short term Debt (2023)

Updated

Inovio Pharmaceuticals' Short term Debt was $16.77 million in Q4 2023, up 1.7% from the prior quarter.

Analysis

Inovio Pharmaceuticals (INO) Short term Debt (2023) Analysis & Trends

From Q1 2023 onward, Inovio Pharmaceuticals has reported Short term Debt for 4 quarters.

  • Per Business Quant data, INO's Short term Debt in the three quarters before Q4 2023 was $16.49 million (Q3 2023), $16.71 million (Q2 2023) and $16.39 million (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Inovio Pharmaceuticals 68.56 Mn -115.11 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 16.77 Mn
Sep 30, 2023 16.49 Mn
Jun 30, 2023 16.71 Mn
Mar 31, 2023 16.39 Mn
API Access

Inovio Pharmaceuticals Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=INO&period=max&api_key=YOUR_API_KEY